期刊
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
卷 16, 期 2, 页码 -出版社
SPRINGER
DOI: 10.1007/s11910-015-0620-7
关键词
Chronic migraine; Cluster headache; Supraorbital transcutaneous stimulator; Cefaly (TM); Transcranial magnetic stimulation; SpringTMS T
资金
- eNeura
- Teva
Migraine and other chronic headache disorders are common and if inadequately treated, can lead to significant disability. The effectiveness of medications can be limited by side effects, drug interactions, and comorbid diseases necessitating alternative methods. Technological developments in the past 5 years have made it possible to use non-invasive methods of neuromodulation to treat primary headache disorders. This field includes technologies such as supraorbital transcutaneous stimulation (STS), transcranial magnetic stimulation (TMS), and non-invasive vagal nerve stimulation (nVNS). Existing trials show these modalities are safe and well tolerated and can be combined with standard pharmacotherapy. We review the technologies, biological rationales, and trials involving non-invasive neuromodulation for the treatment of primary headache disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据